Long-term follow-up study on obstructive hypertrophic cardiomyopathy patients treated with disopyramide: evidences of a notable trend in symptom control within a real-world clinical setting

BackgroundIn obstructive hypertrophic cardiomyopathy (HOCM), disopyramide is used in patients who remain symptomatic despite β-blockers or verapamil. However, effectiveness of disopyramide therapy has not been clearly established due to inconsistent definition of responders and the insufficient leng...

詳細記述

書誌詳細

主要な著者:	Gaetano Todde, Lorenzo Lupo Dei, Roberto Polizzi, Domenico Gabrielli, Grazia Canciello, Silvio Romano, Felice Borrelli, Geza Halasz, Leopoldo Ordine, Salvatore Di Napoli, Daniela Pacella, Raffaella Lombardi, Giovanni Esposito, Federica Re, Maria-Angela Losi
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2024-08-01
シリーズ:	Frontiers in Cardiovascular Medicine
主題:	hypertrophic cardiomyopathy disopyramide obstruction therapy symptoms
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fcvm.2024.1416600/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!